Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             31 results found
no title author magazine year volume issue page(s) type
1 Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines Coughlin, Richard T.
1995
13 1 p. 17-21
5 p.
article
2 Adventitious pestivirus RNA in live virus vaccines against bovine and swine diseases Harasawa, Ryô
1995
13 1 p. 100-103
4 p.
article
3 A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections de la Maza, Michael A.
1995
13 1 p. 119-127
9 p.
article
4 An experimental chemically inactivated HIV-1 vaccine induces antibodies that neutralize homologous and heterologous viruses Race, Esther
1995
13 1 p. 54-60
7 p.
article
5 Calendar 1995
13 1 p. 136-
1 p.
article
6 Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations Stieneker, Frank
1995
13 1 p. 45-53
9 p.
article
7 Considerations on the use of Neisseria meningitidis class 5 proteins as meningococcal BC vaccine components Sacchi, Claudio Tavares
1995
13 1 p. 112-118
7 p.
article
8 Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants Al-Shakhshir, Ragheb H.
1995
13 1 p. 41-44
4 p.
article
9 Cross-protection against influenza virus infection in mice vaccinated by combined nasal/subcutaneous administration Asanuma, Hideki
1995
13 1 p. 3-5
3 p.
article
10 Does envelope V3 peptide comprise the principal neutralizing determinant for HIV? Slobod, Karen S.
1995
13 1 p. 129-
1 p.
article
11 Editorial Board 1995
13 1 p. IFC-
1 p.
article
12 Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigs Bernstein, David I.
1995
13 1 p. 72-76
5 p.
article
13 Effects of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen Tamura, Mizuho
1995
13 1 p. 77-82
6 p.
article
14 Evaluation of a recombinant Schistosoma mansoni 28 kDa antigen for vaccination of zebu calves against S. bovis Aradaib, Imadeldin E.
1995
13 1 p. 130-
1 p.
article
15 Evaluation of booster doses of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children Scheifele, David W.
1995
13 1 p. 104-108
5 p.
article
16 Flavivirus e.g. variola virus recombinant surface antigen protein production and expression using e.g. a vacconia virus vector; application as an attenuated recombinant vaccine 1995
13 1 p. 128-
1 p.
article
17 Human immunodeficiency virus-1 principal neutralizing domain peptide-toxin A conjugate vaccine Cryz Jr, S.J.
1995
13 1 p. 67-71
5 p.
article
18 Immunogenicity in calves of a crude ribosomal fraction of Trichophyton verrucosum: A field trial Elad, D.
1995
13 1 p. 83-87
5 p.
article
19 Modified recombinant virus; antitumour recombinant vaccine production with vaccinia virus or canarypox virus vector and tumour necrosis factor, tumour-associated antigen, interleukin, interferon gene, etc. 1995
13 1 p. 128-
1 p.
article
20 Nucleic acid vaccines Spier, R.E.
1995
13 1 p. 131-132
2 p.
article
21 Protection of goats against peste des petits ruminants with recombinant capripoxviruses expressing the fusion and haemagglutinin protein genes of rinderpest virus Romero, C.H.
1995
13 1 p. 36-40
5 p.
article
22 Protection of guinea-pigs from experimental Rocky Mountain spotted fever by immunization with baculovirus-expressed Rickettsia rickettsii rOmpA protein Sumner, John W.
1995
13 1 p. 29-35
7 p.
article
23 Recombinant vaccine composed of luminal antigen domain, cytoplasm endosome-lysosome targeting signal and a recombinant vaccinia virus vector; DNA sequence; potential cancer gene therapy 1995
13 1 p. 128-
1 p.
article
24 Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates Baqar, Shahida
1995
13 1 p. 22-28
7 p.
article
25 Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers Kärnell, Anders
1995
13 1 p. 88-99
12 p.
article
26 Simultaneous injection of plasma-derived or recombinant hepatitis B vaccines with yellow fever and killed polio vaccines Coursaget, P.
1995
13 1 p. 109-111
3 p.
article
27 The Hitchner B1 strain of Newcastle disease virus induces high levels of IgA, IgG and IgM in newly hatched chicks Russell, P.H.
1995
13 1 p. 61-66
6 p.
article
28 The sixth international conference on Lyme Borreliosis: Progress on the development of lyme disease vaccines Edelman, Robert
1995
13 1 p. 133-135
3 p.
article
29 Vaccination with a formalin-killed P-fimbriated E. coli whole-cell vaccine prevents renal scarring from pyelonephritis in the non-human primate Roberts, J.A.
1995
13 1 p. 11-16
6 p.
article
30 Vaccine-related determinants of the interleukin-2 response to influenza vaccination in healthy young and elderly adults McElhaney, Janet E.
1995
13 1 p. 6-10
5 p.
article
31 Yersinia enterocolitica and Yersinia pseudotuberculosis invasive structural gene inv expression in Escherichia coli using plasmid pBR322; application as a recombinant vaccine and in pathogen screening 1995
13 1 p. 128-
1 p.
article
                             31 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands